Professor Maher is a renowned public health scientist who applies both epidemiological and anthropological approaches to important public health problems – in particular hepatitis C virus (HCV) infection – including leading the first ever HCV vaccine preparedness study. Her high standing is evidenced by extensive conference invitations as well as an outstanding record of competitive grant funding. This is matched by the respect she enjoys in the wider community, as evidenced by invitations to join high level policy and advisory committees, including the WHO Strategic and Technical Advisory Committee on Viral Hepatitis. She would be a most influential addition to the Fellowship.